diagnost anim health
develop market life scienc
tool integr system analyz nucleic
acid creat develop market
life scienc tool integr system
requir disclosur end report
solid number conserv guid reiter buy
view current cl king meet event calendar coverag univers calendar
solidli beat estim kept annual revenu guidanc intact
suggest investor tweak revenu expect
slightli known conservat compani lap
tough comp quarter unconcern approach soft
fact rais number thesi
compani five year unobstruct growth production-scal
sequenc investor underappreci abil scale sb
chemistri think novaseq shore weak near term
reiter buy rate price target
high-level quarter review pretti decent beat kept
revenu guidanc intact reflect stock order china
ep guidanc rais reflect beat howev still impli
model stay put novaseq placement like line given
target remain intact view posit
given rumor shortfal prior quarter
thesi quarter near-term oper perform expect
said long-term macro seem robust today
go quarter cite number opportun across
nipt liquid biopsi incorpor genom data health care
medic record net-net long-term demand sequenc remain strong
remain bullish particularli follow stock irrat sell-off
report revenu vs
beat our/th street respect estim
non-gaap ep beat our/street expect
maintain revenu guidanc approxim
rais adjust ep rang ep rang
compani previous guid adjust ep rang
ep rang
model leav respect revenu estim
intact rais adjust ep forecast
respect note
model review run addit custom proprietari check
valuat price target unchang base price-to-earnings multipl
revis ep estim multipl
reduct reflect pass quarter although stock current
trade premium stock diagnost space believ
year unobstruct growth multibillion-dollar address
market multipl high end stock histor trade
rang howev visibl growth barrier entri never
risk achiev price target
increas competit space
inabl protect proprietari technolog
adopt speed novaseq
decreas govern spend
chang fda rule
page
